We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+14.19%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$117B
AUM Growth
+$9.87B
(+9.2%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
4,391
New
216
Increased
2,182
Reduced
1,537
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$89.2M |
| 2 |
Flutter Entertainment
FLUT
|
+$43.9M |
| 3 |
Okta
OKTA
|
+$32.1M |
| 4 |
Chewy
CHWY
|
+$31.8M |
| 5 |
Coinbase
COIN
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DFS
Discover Financial Services
DFS
|
+$91M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$75.5M |
| 3 |
Amazon
AMZN
|
+$71.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$71.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$68.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.83% |
| 2 | Financials | 13.86% |
| 3 | Consumer Discretionary | 10.91% |
| 4 | Healthcare | 9.41% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
SoundThinking
SSTI
$107M
| $208K | ﹤0.01% |
15,960
+980
| +7% | +$15.3K |
|
2977
Puma Biotechnology
PBYI
$450M
| $208K | ﹤0.01% |
60,611
+22,316
| +58% | +$71.2K |
|
|
SCPH
2978
DELISTED
scPharmaceuticals
SCPH
| $208K | ﹤0.01% |
54,500
+3,001
| +6% | +$9.32K |
|
2979
Foghorn Therapeutics
FHTX
$385M
| $208K | ﹤0.01% |
44,165
+7,920
| +22% | +$33.1K |
|
2980
Holley
HLLY
$362M
| $207K | ﹤0.01% |
103,287
+34,914
| +51% | +$74.1K |
|
2981
LifeVantage
LFVN
$81.9M
| $206K | ﹤0.01% |
15,775
+15,219
| +2,737% | +$197K |
|
|
FFNW
2982
DELISTED
First Financial Northwest, Inc
FFNW
| $205K | ﹤0.01% |
9,099
+2,300
| +34% | +$52.1K |
|
|
CRGX
2983
DELISTED
CARGO Therapeutics
CRGX
| $205K | ﹤0.01% |
49,795
+2,392
| +5% | +$10.2K |
|
2984
First Internet Bancorp
INBK
$256M
| $205K | ﹤0.01% |
7,622
-507
| -6% | -$12.1K |
|
2985
Gold Fields
GFI
$35.4B
| $205K | ﹤0.01% |
8,659
| – | – |
|
2986
Inhibrx
INBX
$1.42B
| $205K | ﹤0.01% |
14,334
-1,098
| -7% | -$14.2K |
|
|
JBS
2987
JBS N.V.
JBS
$43.8B
| $203K | ﹤0.01% |
+13,928
| New | +$196K |
|
2988
SEACOR Marine Holdings
SMHI
$262M
| $203K | ﹤0.01% |
39,862
-6,819
| -15% | -$34.5K |
|
2989
Norwood Financial Corp
NWFL
$376M
| $203K | ﹤0.01% |
7,866
+380
| +5% | +$9.52K |
|
2990
Investar Holding Corp
ISTR
$425M
| $202K | ﹤0.01% |
10,451
+1,182
| +13% | +$21.8K |
|
2991
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $202K | ﹤0.01% |
7,286
-55,414
| -88% | -$1.41M |
|
2992
Acacia Research
ACTG
$449M
| $201K | ﹤0.01% |
56,276
+1,907
| +4% | +$6.57K |
|
2993
TIM SA
TIMB
$8.27B
| $201K | ﹤0.01% |
10,018
+5,417
| +118% | +$92.7K |
|
2994
PrimeEnergy Resources
PNRG
$316M
| $201K | ﹤0.01% |
1,373
+684
| +99% | +$119K |
|
|
FVR
2995
FrontView REIT
FVR
$487M
| $200K | ﹤0.01% |
16,688
+1,288
| +8% | +$15.2K |
|
|
KMTS
2996
Kestra Medical Technologies
KMTS
$1.63B
| $200K | ﹤0.01% |
+12,051
| New | +$263K |
|
2997
First National Corp
FXNC
$291M
| $199K | ﹤0.01% |
+10,223
| New | +$202K |
|
2998
Stellantis
STLA
$20.2B
| $199K | ﹤0.01% |
19,802
-107
| -0.5% | -$1.05K |
|
|
HIMX
2999
Himax Technologies
HIMX
$2.56B
| $198K | ﹤0.01% |
22,121
-4,024
| -15% | -$31.7K |
|
3000
Chemung Financial Corp
CHMG
$403M
| $197K | ﹤0.01% |
4,074
+883
| +28% | +$40.5K |
|
Similar funds
RhumbLine Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, RhumbLine Advisers held 4,391 positions worth $117B, up 9.2% from $107B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
RhumbLine Advisers's Q2 2025 filing shows 216 new, 2,182 increased, 1,537 reduced and 202 closed positions. Its largest new stake was Ralliant Corp: 320,982 shares worth $15.6M. The largest sale was Discover Financial Services, an estimated $91M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q2 2025 buy was Ralliant Corp: 320,982 shares worth $15.6M.
- RhumbLine Advisers added most to Capital One in Q2 2025, an estimated $89.2M increase.
- RhumbLine Advisers's biggest Q2 2025 reduction was iShares Russell 2000 ETF, cutting an estimated $75.5M.
- RhumbLine Advisers fully exited Discover Financial Services in Q2 2025, selling an estimated $91M.
- RhumbLine Advisers's ten largest holdings make up 31% of its $117B portfolio in Q2 2025.
- RhumbLine Advisers opened 216 new positions and closed 202 in Q2 2025.
- RhumbLine Advisers's portfolio value rose 9.2% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.